Effects of Ramipril and Rosiglitazone on Cardiovascular and Renal Outcomes in People With Impaired Glucose Tolerance or Impaired Fasting Glucose: Results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial Article

author list

  • Dagenais, G. R.; Gerstein, H. C.; Holman, R.; Budaj, A.; Escalante, A.; Hedner, T.; Keltai, M.; Lonn, E.; McFarlane, S.; McQueen, M.; Teo, K.; Sheridan, P.; Bosch, J.; Pogue, J.; Yusuf, S.; DREAM Trial Investigators


publication date

  • 2008

published in


number of pages

  • 7

start page

  • 1007

end page

  • 1014


  • 31


  • 5